信件：关于重新启动慢性胃肠道疾病临床服务的相关建议——新冠疫情时期该如何及何时实施？作者回复。
Letter: Covid-19-re-initiating clinical services for chronic gastrointestinal diseases. How and when? Authors' reply.
机构信息
Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, Vic., Australia.
出版信息
Aliment Pharmacol Ther. 2020 Oct;52(8):1416-1417. doi: 10.1111/apt.16065.
Abstract
This article is linked to Al‐Ani et al and Britton et al papers. To view these articles, visit https://doi.org/10.1111/apt.15779 and https://doi.org/10.1111/apt.16061
摘要
本文与 Al-Ani 等人和 Britton 等人的论文相关联。要查看这些文章，请访问 https://doi.org/10.1111/apt.15779 和 https://doi.org/10.1111/apt.16061。
相似文献
1
Letter: Covid-19-re-initiating clinical services for chronic gastrointestinal diseases. How and when? Authors' reply.
Aliment Pharmacol Ther. 2020 Oct;52(8):1416-1417. doi: 10.1111/apt.16065.
2
Letter: Covid-19-re-initiating clinical services for chronic gastrointestinal diseases. How and when?
Aliment Pharmacol Ther. 2020 Oct;52(8):1414-1415. doi: 10.1111/apt.16061.
3
Letter: SARS-CoV-2 induced gastrointestinal inflammation-authors' reply.
Aliment Pharmacol Ther. 2020 Dec;52(11-12):1750-1751. doi: 10.1111/apt.16117.
4
Dangerous interactions of gastrointestinal drugs with experimental treatments for COVID-19.
Eur J Gastroenterol Hepatol. 2020 Nov;32(11):1481. doi: 10.1097/MEG.0000000000001778.
5
Letter: Liver injury in COVID-19: Diagnosis and associated factors-Authors' reply.
Liver Int. 2020 Aug;40(8):2041. doi: 10.1111/liv.14511. Epub 2020 Jun 10.
6
Gastrointestinal and liver involvement in patients with COVID-19 - Authors' reply.
Lancet Gastroenterol Hepatol. 2020 Sep;5(9):799-800. doi: 10.1016/S2468-1253(20)30240-5.
7
Letter: IBD nurse-pivotal role in the time of the pandemic. Authors' reply.
Aliment Pharmacol Ther. 2020 Aug;52(4):746-747. doi: 10.1111/apt.15954.
8
Invisible spread of SARS-CoV-2 - Authors' reply.
Lancet Infect Dis. 2020 Sep;20(9):1012. doi: 10.1016/S1473-3099(20)30275-9. Epub 2020 Apr 8.
9
Letter: Covid-19, and vitamin D. Authors' reply.
Aliment Pharmacol Ther. 2020 May;51(10):995-996. doi: 10.1111/apt.15764.
10
Authors' Reply.
J Am Soc Nephrol. 2020 Sep;31(9):2225-2226. doi: 10.1681/ASN.2020060847. Epub 2020 Aug 12.
本文引用的文献
1
Letter: Covid-19-re-initiating clinical services for chronic gastrointestinal diseases. How and when?
Aliment Pharmacol Ther. 2020 Oct;52(8):1414-1415. doi: 10.1111/apt.16061.
2
Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty.
Intern Med J. 2020 Jul;50(7):798-804. doi: 10.1111/imj.14889.
3
Inflammatory Bowel Disease in the COVID-19 Pandemic: the Patients' Perspective.
J Crohns Colitis. 2020 Dec 2;14(12):1702-1708. doi: 10.1093/ecco-jcc/jjaa126.
4
Telehealth in the Context of COVID-19: Changing Perspectives in Australia, the United Kingdom, and the United States.
J Med Internet Res. 2020 Jun 9;22(6):e19264. doi: 10.2196/19264.
5
Review article: prevention, diagnosis and management of COVID-19 in the IBD patient.
Aliment Pharmacol Ther. 2020 Jul;52(1):54-72. doi: 10.1111/apt.15779. Epub 2020 May 26.
6
Videoconference clinics improve efficiency of inflammatory bowel disease care in a remote and rural setting.
J Telemed Telecare. 2020 Oct;26(9):545-551. doi: 10.1177/1357633X19849280. Epub 2019 Jun 5.
7
Development and Feasibility Study of a Telemedicine Tool for All Patients with IBD: MyIBDcoach.
Inflamm Bowel Dis. 2017 Apr;23(4):485-493. doi: 10.1097/MIB.0000000000001034.
8
Integration of Telemedicine Into Clinical Gastroenterology and Hepatology Practice.
Clin Gastroenterol Hepatol. 2017 Feb;15(2):175-181. doi: 10.1016/j.cgh.2016.09.011. Epub 2016 Dec 16.
9
EHealth Technologies in Inflammatory Bowel Disease: A Systematic Review.
J Crohns Colitis. 2016 Sep;10(9):1103-21. doi: 10.1093/ecco-jcc/jjw059. Epub 2016 Feb 29.
Zotero 插件